Keyphrases
Hemodialysis Patients
83%
Chronic Kidney Disease
78%
Secondary Hyperparathyroidism
44%
Anemia
44%
Intravenous Iron
42%
Paricalcitol
36%
Intact Parathyroid Hormone (iPTH)
34%
Erythropoiesis-stimulating Agents
32%
Hemoglobin
32%
Hemodialysis
27%
Serum Phosphorus
26%
Dialysis Patients
22%
Epoetin Alfa
22%
Serum Ferritin
21%
Placebo
20%
Maintenance Hemodialysis Patients
20%
Dialysis
20%
Ferritin
18%
Transferrin Saturation
18%
Sucroferric Oxyhydroxide
17%
Sodium Ferric Gluconate Complex
17%
Leptin
16%
Phosphate Binder
15%
Ferrous Gluconate
14%
End-stage Renal Disease
14%
Chronic Kidney Disease Patients
13%
Serum Calcium
13%
1,25-dihydroxyvitamin D3
13%
Vitamin D
13%
Vitamin D Analogs
13%
Serum Leptin
12%
Peritoneal Dialysis Patients
12%
Cinacalcet
12%
Iron Deficiency
11%
Hypercalcemia
11%
Pill Burden
11%
Calcitriol
10%
Anemia of Chronic Kidney Disease
10%
Vitamin D Receptor Activator
10%
Vascular Calcification
9%
Hyperleptinemia
8%
Hepcidin
8%
Oral Iron
8%
Iron Stores
8%
High Dose
8%
Intravenous Iron Therapy
8%
Anemia Management
8%
Bradykinin
7%
Hypertension
7%
Type 2 Diabetes Mellitus (T2DM)
7%
Pharmacology, Toxicology and Pharmaceutical Science
Hemodialysis
100%
Chronic Kidney Failure
74%
Anemia
53%
Secondary Hyperparathyroidism
42%
Parathyroid Hormone
31%
Ferric Gluconate
26%
Recombinant Erythropoietin
26%
Placebo
24%
Paricalcitol
24%
Ferritin
20%
Adverse Event
18%
Sucroferric Oxyhydroxide
17%
Calcitriol
16%
Phosphate Binding Agent
16%
Transferrin
15%
Iron Deficiency
15%
Antianemic Agent
13%
Vitamin D
13%
End Stage Renal Disease
12%
Kidney Disease
12%
Clinical Trial
12%
Infection
12%
Vitamin D Receptor
11%
Leptin
11%
Prevalence
10%
Vitamin D Deficiency
10%
Hypovitaminosis D
10%
Hepcidin
10%
Cinacalcet
9%
Blood Vessel Calcification
8%
Hypercalcaemia
8%
Prostaglandin Synthase
8%
Hyperphosphatemia
7%
Iron Deficiency Anemia
7%
Vitamin D Analog
7%
Ferumoxytol
7%
Bone Disease
7%
Non Insulin Dependent Diabetes Mellitus
7%
Stimulant
6%
Hyperleptinemia
6%
Cohort Study
6%
Disease
6%
Iron Dextran
6%
Canagliflozin
5%
Bardoxolone Methyl
5%
Nicotinamide
5%
Interleukin 1
5%
Medicine and Dentistry
Hemodialysis
60%
Chronic Kidney Disease
58%
Anemia
37%
Secondary Hyperparathyroidism
30%
Paricalcitol
27%
Parathyroid Hormone
25%
Ferritin
23%
Isotopes of Calcium
22%
Leptin
18%
Hematinic
18%
Placebo
16%
Nephropathy
15%
Sucroferric Oxyhydroxide
14%
Peritoneal Dialysis
14%
End Stage Renal Disease
13%
Iron Deficiency
12%
Transferrin Saturation
12%
Clinical Trial
12%
Phosphate Binder
12%
Iron Supplement
12%
Ferric Gluconate
11%
Vitamin D Receptor
10%
Calcitriol
10%
Vitamin D
10%
Recombinant Erythropoietin
10%
Cinacalcet
9%
Cardiovascular System
9%
Erythropoiesis
8%
Adverse Event
8%
Hepcidin
8%
Transplantation
7%
Hyperleptinemia
7%
Hypercalcaemia
7%
Hormone Determination
7%
Diabetic Nephropathy
7%
Hyperphosphatemia
7%
Kidney Transplantation
7%
Bone Disease
7%
Maturity Onset Diabetes of the Young
7%
Diabetes
6%
Supplementation
6%
Patient with Type 2 Diabetes
6%
Iron
6%
Albuminuria
6%
Canagliflozin
5%
Bardoxolone Methyl
5%
Nicotinamide
5%
Hypochromic Anemia
5%
Disease
5%
Analeptic
5%